Bicycle Therapeutics plc BCYC
3.67 USD +0.05 (+1.38%)
At closeNov 4, 2026, 7:20 AM EST
3.66 -0.01 -0.27%
Pre-market · Nov 4, 7:20 AM ET
3.61 Day range 3.71
3.33 52-week range 7.83
- YTD
- -48.16%
- 1 year
- -49.45%
Analyst view
Consensus: buy
Buy
Price target (mean) 29.55 +705.1% upside
Now 3.67
- Target (low)
- 13.00
- Target (mean)
- 29.55
- Target (high)
- 48.00
Ratings (0m) 13 10 buy · 3 hold · 0 sell
- Strong buy5
- Buy5
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
- 3 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.805 | -0.905 – -0.69 | -0.62 | -29.8% | 8.67M | -55.6% | 5 |
| Next quarter | -0.8206 | -0.943 – -0.69 | -0.77 | -6.6% | 7.86M | -16.0% | 5 |
| Current year | -3.32 | -3.84 – -2.88 | 0.00 | 0.0% | 34.56M | -2.0% | 8 |
| Next year | -3.88 | -4.39 – -3.31 | -3.32 | -17.0% | 33.44M | -3.3% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 26, 2025 | Citizens Capital Markets | Reiterated | Market Outperform | Market Outperform |
| Feb 26, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 26, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 22, 2025 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Jan 13, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 13, 2025 | Needham | Reiterated | Buy | Buy |
| Dec 18, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Dec 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 13, 2024 | B. Riley Securities | Maintained | Neutral | Neutral |
| Nov 8, 2024 | Stephens & Co. | Initiated | — | Equal-Weight |
| Nov 1, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 24, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 16, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 9, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Sep 6, 2024 | RBC Capital | Initiated | — | Outperform |
| Aug 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 7, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 7, 2024 | B. Riley Securities | Downgrade | Buy | Neutral |
| May 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Feb 21, 2024 | Canaccord Genuity | Reiterated | Buy | Buy |
| Feb 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 21, 2024 | Needham | Reiterated | Buy | Buy |
